epirubicin has been researched along with Necrotizing Enterocolitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Friese, K; Janni, JW; Klanner, E; Rack, B; Sommer, H | 1 |
1 other study(ies) available for epirubicin and Necrotizing Enterocolitis
Article | Year |
---|---|
[Chemotherapy-associated enterocolitis--a rare but potentially lethal side effect of adjuvant breast cancer treatment: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Enterocolitis, Necrotizing; Epirubicin; Fatal Outcome; Female; Humans; Intestinal Pseudo-Obstruction; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Reoperation; Taxoids; Treatment Failure | 2004 |